Poster presented at ESMO 2018 Congress: 430P - Phase I study: Safety and tolerability of Varlitinib (VAR) in combination with Oxaliplatin and Capecitabine (COX) or Oxaliplatin and 5-FU (FOL) in advanced solid
European Society for Medical Oncology (ESMO) Congress (2018) | BeyondSpring
Information for Presenters | ESMO TAT 2023
ESMO Asia 2018 Congress | Singapore Oncology Conference
Webcasts & Presentations | ESMO 2018 Congress
GUSTAVE ROUSSY AT ESMO 2018
European Society for Medical Oncology
Industry Sponsored Satellite Symposia | ESMO
Information for Presenters | ESMO Congress 2023
ACT Genomics SG - ACT Genomics is proud to be selected for abstract poster presentation in ESMO 2018 Congress which starting from today till 23 October at Munich, Germany. In one of
Top News From ESMO 2018: Slideshow
PosterSessionOnline
ESMO - Eur. Oncology on X: "#ESMO18 is slowly coming to a close. The science, the education, the peer connections; everything came together for an exceptional congress. Many thanks to all of
Abstracts | ESMO Congress 2022
ESMO 2018 Congress | ID SOLUTIONS
INCA Best Poster ESMO Munich 2018 | NETwork!
Biocytogen at the at the European Society for Medical Oncology (ESMO) 2018 annual meeting - Biocytogen
ESDO: GI Slide Decks
Information for Presenters | ESMO Immuno-Oncology Congress 2023
ESMO 2018 - Day 1 | European Society for Medical Oncology | Flickr